Juan Arciniega, MD
Basic profileThe University of Texas Southwestern Medical Center
Juan Arciniega is an Ophthalmology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 15 publications with 266 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1309 E Ridge Rd
Suite 1
Mcallen, TX 785031517
Telephone
956-631-8875Registry record last updated 28 Dec 2015.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20252 payments
- Sight Sciences, Inc.Program year20252 payments
- Bausch & Lomb Americas Inc.Program year202410 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
87.9%Corticosteroid26.4%Prednisolone Acetate100%Part D≥527 patientsProstaglandin Analog17.1%Latanoprost89%Lumigan8%Travoprost3%Part D<11 patients+ 7 more classes in this area
Cancer & immunology
4.9%Calcineurin inhibitor4.9%Restasis52%Cyclosporine48%Part D≥40 patientsCardiovascular
2.6%Beta blocker2.6%Timolol Maleate100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Disruption and Destabilization of Meibomian Lipid Films Caused by Increasing Amounts of Ceramides and Cholesterol
Investigative Ophthalmology & Visual Science
2013 - Laser In Situ Keratomileusis Retreatment with Wavefront-Optimized Technique after Primary Wavefront-Guided LASIK: Proof of Concept
DOAJ (DOAJ: Directory of Open Access Journals)
2013 - Evaluation and Quantitation of Intact Wax Esters of Human Meibum by Gas-Liquid Chromatography-Ion Trap Mass Spectrometry
Investigative Ophthalmology & Visual Science
2012 - Amphiphilic Lipid Effects On Mixed Lipid Films And Their Implications For The Tear Film Lipid Layer
Investigative Ophthalmology & Visual Science
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Margaret Pearle, MD, PhD
The University of Texas Southwestern Medical Center
George Buchanan, MD
The University of Texas Southwestern Medical Center
Vitaly Margulis, MD
The University of Texas Southwestern Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”